Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Appetite suppressants are restricted due to the adverse neurological effects they can cause
Details surrounding Medicaid coverage are varied due to the opt-in nature of the program
The good news is that with GLP-1s, she can treat both obesity/overweight and these associated metabolic diseases
Shortly after food intake, the human body releases a hormone called glucagon-like peptide-1
See if you may qualify Tirzepatide is the active ingredient in 2 prescription medications: Mounjaro for controlling blood sugar levels in people with type 2 diabetes, and Zepbound for weight loss and weight management
Second Natures peer-reviewed research directly compared both medications when combined with behavioural support, finding Mounjaro users lost 22.1% of their starting weight while Wegovy (up to 2.4 mg) users lost 17.1% at 12 months
US$ 22.04
US$ 22.30
US$ 23.94
